SCHEMBL124763

SCHEMBL124763

Nc1c(I)cc(I)c(C(=O)O)c1I

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
LMNA P02545 2/20 0.44
CYP2C9 P11712 2/20 0.44
CHRM1 P11229 1/20 0.44
TBXA2R P21731 1/20 0.44
PDE4A P27815 1/20 0.44
ADRA1A P35348 1/20 0.44
CYP1A2 P05177 1/20 0.44
HIF1A Q16665 1/20 0.44
TPMT P51580 1/20 0.41
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
CA9 Q16790 2/20 0.34
KDM4E B2RXH2 4/20 0.33
KMT2A Q03164 3/20 0.33
GFER P55789 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
MEN1 O00255 1/20 0.32
USP2 O75604 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29394151 1.00 TSHR (0.46) TSHRMAPK1LMNACYP2C9CHRM1
SCHEMBL6396616 0.98 TSHR (0.45) TSHRMAPK1LMNACYP2C9CHRM1
Butanedione SCHEMBL27926797 0.91 LMNA (0.44) TSHRMAPK1LMNACYP2C9CHRM1
Acrylamide SCHEMBL8663429 0.88 TSHR (0.39) TSHRMAPK1LMNACYP2C9CHRM1
Glutarate SCHEMBL11207827 0.88 TSHR (0.49) TSHRMAPK1LMNACYP2C9CHRM1
SCHEMBL377395 0.84 MAPK1 (0.53) TSHRMAPK1LMNACYP2C9CHRM1
Tetraethylene Glycol SCHEMBL11821634 0.83 TSHR (0.39) TSHRMAPK1LMNACYP2C9CHRM1
SCHEMBL31534599 0.83 KDM4E (0.41) TSHRMAPK1CYP2C9HIF1ATPMT
SCHEMBL27979892 0.83 TPMT (0.46) TSHRMAPK1LMNACYP2C9CHRM1
SCHEMBL6012587 0.83 LMNA (0.40) TSHRMAPK1LMNACYP2C9CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024017165-A1 METHOXYPOLYETHYLENE GLYCOL-POLY(LACTIC-CO-GLYCOLIC ACID)-POLYLYSINE-BASED DEVELOPING POROUS MICROSPHERE, PREPARATION METHOD, AND USE 森心(上海)科技有限公司 2024-01-25 WO claimed
CN-115252877-A Iodopolyethylene glycol-polylactic glycolic acid-polylysine development porous microsphere, preparation method and application 上海市肿瘤研究所 2022-11-01 CN claimed
CN-114437344-A Room-temperature phosphorescent polyamide copolymer and preparation method and application thereof 中国石油化工股份有限公司 2022-05-06 CN claimed
CN-114057600-A X-ray developable molecule, drug-loaded embolism microsphere and preparation method thereof 上海汇禾医疗科技有限公司 2022-02-18 CN claimed
US-20210069352-A1 IODINE-BASED PARTICLES NANOPROBES, INC. 2021-03-11 US claimed
CN-105194693-B For CT imagings and the golden shell parcel iodo nano-particle of photo-thermal therapy and its preparation 天津医科大学 2018-03-27 CN claimed
US-20170274101-A1 IODINE-BASED PARTICLES NANOPROBES, INC. 2017-09-28 US claimed
WO-2017165841-A1 IODINE-BASED PARTICLES NANOPROBES, INC. (US) 2017-09-28 WO claimed
CN-106007818-A Full-automatic-temperature-control refuse fermentation apparatus and operating method thereof 徐州工程学院 2016-10-12 CN claimed
CN-105194693-A Golden-shell covered iodo-nanoparticle for CT imaging and photo-thermal treatment and preparation of golden-shell covered iodo-nanoparticle UNIV TIANJIN MEDICAL 2015-12-30 CN claimed
US-5141739-A Delivery of x-ray contrast agents using receptor mediated endocytosis ADVANCED MAGNETICS, INC. (US) 1992-08-25 US claimed
CN-118184679-A Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material 中国石油天然气股份有限公司 2024-06-14 CN disclosed
CN-114057600-B X-ray developable molecule, drug-loaded embolism microsphere and preparation method thereof 上海汇禾医疗科技股份有限公司 2024-02-02 CN disclosed
CN-117323459-A Developable embolism microsphere and preparation method and application thereof 至微(深圳)医学科技有限公司 2024-01-02 CN disclosed
US-11774853-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-10-03 US disclosed
US-4031088-A Iodinated anilic acids STERLING DRUG INC. (US) 1977-06-21 US disclosed
US-4031088-A Iodinated anilic acids STERLING DRUG INC. (US) 1977-06-21 US disclosed
US-4001298-A RADIOPAQUE AGENTS SCHERING AKTIENGESELLSCHAFT (DT) 1977-01-04 US disclosed
US-3853866-A 3-AMINO-2,4,6-TRIIODOBENZOIC ACID DERIVATIVES CHEMIE HOLDING AKTIENGESELLSCHAFT 1974-12-10 US disclosed
US-3853866-A 3-AMINO-2,4,6-TRIIODOBENZOIC ACID DERIVATIVES CHEMIE HOLDING AKTIENGESELLSCHAFT 1974-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170274101-A1 IODINE-BASED PARTICLES TPO, BRI3BP, INSRR TSHR 25/4885MAPK1 3330/4885LMNA 3921/4885
US-20210069352-A1 IODINE-BASED PARTICLES TPO, BRI3BP, INSRR TSHR 25/4885MAPK1 3330/4885LMNA 3921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.